EMPFIELD JAMES R. (SVP, Drug Discovery) sold 85.2% of their position (57.74K shares) of XENON PHARMACEUTICALS INC. on the open market
Open‑market sale worth $2.21M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Shares
Shares
+20K
Price / share
$3.10
Trade value
$62K
% of position
Common Shares
Shares
+45K
Price / share
$4.75
Trade value
$213.75K
% of position
Common Shares
Shares
−7.26K
Price / share
$38.02
Trade value
$275.91K
% of position
Common Shares
Shares
−35.87K
Price / share
$38.08
Trade value
$1.37M
% of position
Common Shares
Shares
−21.88K
Price / share
$38.68
Trade value
$846.13K
% of position
Net shares
+0.00
Net value
-$2.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/12/2022 | M · Option Exercise | +20K | $3.10 | $62K | 200.0% | 10K | 30K |
| Common Shares Direct | 8/12/2022 | M · Option Exercise | +45K | $4.75 | $213.75K | 150.0% | 30K | 75K |
| Common Shares Direct | 8/12/2022 | F · Tax Withholding | −7.26K | $38.02 | $275.91K | 9.7% | 75K | 67.74K |
| Common Shares Direct | 8/12/2022 | S · Sale | −35.87K | $38.08 | $1.37M | 52.9% | 67.74K | 31.88K |
| Common Shares Direct | 8/12/2022 | S · Sale | −21.88K | $38.68 | $846.13K | 68.6% | 31.88K | 10K |
| Total | +0.00 | -$2.21M | ||||||
Stock Option (Right to Buy)
Common Shares
20K shares
Shares
−20K
Strike price
3.10
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Shares
45K shares
Shares
−45K
Strike price
4.75
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares20K shares | 8/12/2022 | M · Option Exercise | −20K | 3.10 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Shares45K shares | 8/12/2022 | M · Option Exercise | −45K | 4.75 | — | 0.00 |